Table 1.
Clinical characteristics of the patients (n = 109)
| Parameter | |
|---|---|
| Age, y | 71 ± 10 |
| Male (%) | 50 |
| Body mass index (kg/m2) | 24 ± 4 |
| Current smoker (%) | 17 |
| Hypertension (%) | 77 |
| Hyperlipidemia (%) | 53 |
| Atrial fibrillation (%) | 6 |
| Valvular diseases (%) | 10 |
| History of cardiovascular diesases (N/C/H) | 80/13/16 |
| Systolic blood pressure (mmHg) | 137 ± 16 |
| Diastolic blood pressure (mmHg) | 71 ± 11 |
| Fasting blood glucose (mg/dL) | 137 ± 44 |
| Hemoglobin A1c (%) | 6.6 ± 1.5 |
| Total cholesterol (mg/dL) | 204 ± 35 |
| Triglyceride (mg/dL) | 113 [86, 158] |
| Serum creatinine (mg/dL) | 0.8 ± 0.3 |
| Urinary albumin (mg/gCreatinine) | 33 [13, 139] |
| BNP (pg/mL) | 26.7 [14.3, 57.2] |
| CRP (mg/dL) | 0.10 [0.04, 0.20] |
| Sulfonylurea (%) | 48 |
| Biguanide (%) | 3 |
| α-glycosidase inhibitor (%) | 34 |
| thiazolidinedione (%) | 6 |
| Glinide (%) | 8 |
| ACEI (%) | 17 |
| ARB (%) | 11 |
| β-blocker (%) | 16 |
| Calcium channel blocker (%) | 55 |
| Diuretics (%) | 9 |
| Aspirin (%) | 13 |
| Statin (%) | 24 |
Notes: Data are presented as means ± SD, percentage or median [25, 75 percentiles] of the values.
Abbreviations: ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II type 1 receptor blocker; N, C and H indicates none of any past cardiovascular diseases, cerebral infarction/hemorrhage or heart diseases, such as angina pectoris, myocardial infarction and heart failure.